The U.S. Food and Drug Administration approved dupilumab for eosinophilic esophagitis in patients 12 and up in May 2022. This… Read more »
Tag: AAAAI
Extra Inhaler Strategy Cut Asthma Attacks for Black, Latinx Adults
With asthma, it’s well-known that Black and Latinx populations in the United States bear a disproportionate level of disease burden.… Read more »
Fecal Transplant Pills Show Promise in Treating Food Allergies
Fecal microbiota transplants (FMT) enabled some with severe peanut allergy to consume up to two peanuts without reacting, early clinical… Read more »
Study Finds Getting Epi Early Prevents Uncontrolled Allergic Reactions
A data analysis presented at the AAAAI allergists’ annual meeting reinforces the importance of prompt self-administration of epinephrine to treat… Read more »
Parents Who Feed Peanut to Babies Willing to Try Other Allergens Too
If parents are willing to introduce peanut to a baby under six months old, they’re then far more likely also… Read more »
Asthma News: Sinusitis’s Impact, Shot Brings 4-Season Relief
Chronic Sinusitis’s Impact on Asthma Asthmatics can add chronic rhinosinusitis (CRS) as a related condition, and one that has a… Read more »
Mast Cell Disorder Patients Tolerating COVID-19 Vaccine
COVID-19 vaccines can be tolerated by most patients with confirmed mast cell activation syndrome (MCAS), according to a study that… Read more »
A Blood Test to Diagnose EoE Triggers? Researchers Make Progress
Researchers have identified a biomarker in the blood that appears to reliably determine when milk is a trigger for eosinophilic… Read more »
AAAAI News: Dupilumab Remission; Tezepelumab in Severe Asthma; Palforzia Safety
Dupilumab Led to Asthma Remission for Some About 30 percent of patients taking the biologic drug dupilumab experienced “remission” of… Read more »
Cat Therapy Aims to Block Wheezing and Asthma Misery
An experimental cat therapy treatment helped asthmatics with cat allergies to spend several hours exposed to cat allergens without wheezing… Read more »